Firm to Research Cannabis Treatments Under NIH Deal

A pharmaceutical company has inked a licensing agreement with the National Institutes of Health (NIH) to develop, test and possibly sell cannabis-based drugs for use in treating head trauma. Under the agreement, KannaLife Sciences will research CBD and other cannabis-derived treatments for chronic traumatic encephalopathy (CTE), a degenerative brain condition most common among athletes who […]

Firm to Research Cannabis Treatments Under NIH Deal is a post from: Marijuana Business Daily - Legal, Financial and Dispensary News